Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 38.44B | 39.32B | 41.32B | 33.82B | 12.19B | 10.67B |
Gross Profit | 16.64B | 16.35B | 16.80B | 13.38B | 7.57B | 6.81B |
EBITDA | 22.96B | 11.61B | 22.37B | 14.17B | 7.15B | 6.69B |
Net Income | 768.00M | -11.31B | -3.13B | -7.37B | 1.01B | 1.22B |
Balance Sheet | ||||||
Total Assets | 101.73B | 104.56B | 122.76B | 134.00B | 34.43B | 34.09B |
Cash, Cash Equivalents and Short-Term Investments | 4.89B | 5.31B | 3.78B | 3.73B | 3.90B | 2.09B |
Total Debt | 34.63B | 39.51B | 43.67B | 49.00B | 14.76B | 15.40B |
Total Liabilities | 64.38B | 69.62B | 76.28B | 85.33B | 21.03B | 21.70B |
Stockholders Equity | 36.05B | 34.04B | 45.23B | 47.09B | 11.60B | 10.46B |
Cash Flow | ||||||
Free Cash Flow | 4.07B | 4.43B | 6.16B | 3.32B | 2.42B | 2.34B |
Operating Cash Flow | 5.10B | 5.38B | 7.48B | 4.30B | 2.80B | 2.74B |
Investing Cash Flow | -643.00M | -349.00M | -1.26B | 3.52B | -56.00M | -703.00M |
Financing Cash Flow | -3.36B | -3.75B | -5.84B | -7.74B | -853.00M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | 510.87B | 51.23 | 41.07% | ― | 14.28% | 46.86% | |
78 Outperform | 24.84B | 11.97 | 18.92% | 0.94% | 16.60% | 57.39% | |
76 Outperform | 207.88B | 18.13 | 10.58% | 0.86% | 5.00% | 144.65% | |
76 Outperform | 24.84B | 10.81 | 18.92% | 1.04% | 16.60% | 57.39% | |
68 Neutral | $48.18B | 64.44 | 2.18% | ― | -3.79% | ― | |
67 Neutral | 17.45B | 36.71 | 13.45% | 0.67% | -11.42% | 75.42% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |